Zobrazeno 1 - 10 of 23 pro vyhledávání: '"Edward Drea"'
1
Akademický článek
An economic evaluation of cabazitaxel versus a second androgen receptor-targeted agent (ARTA) for patients with metastatic castration-resistant prostate cancer previously treated with docetaxel and an ARTA: the United States payer perspective
Autor: Alicia K. Morgans, Thomas Hutson, Alice Kai Dan Guan, David Garcia, Anna Zhou, Edward Drea, Nicholas J. Vogelzang
Publikováno v: BMC Health Services Research, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Cabazitaxel significantly improves clinical outcomes compared with a second androgen receptor-targeted agent (ARTA) in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel and an
Externí odkaz: https://doaj.org/article/6d4b407f4b4b48b78c689dd2fe67da45
Zobrazit plný text záznamu
8
Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP)
Autor: Ian Chau, Edward Drea, Mikhail Fedyanin, Jorge Aparicio, M. Ter-Ovanesov, Marc Peeters, Roberto Bordonaro, Irfan Cicin, Yoo Joung Ko, Pilar García-Alfonso, Pascaline Picard, Volker Heinemann, Evaristo Maiello, Vichien Srimuninnimit, Denise Bury, Maria Di Bartolomeo, Meinolf Karthaus, Petr Kavan, Alberto Sobrero, Rachel P. Riechelmann, Carlos Fernández Martos, Suayib Yalcin
Publikováno v: Clinical colorectal cancer
CLINICAL COLORECTAL CANCER
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
This study evaluated safety and quality of life in patients with metastatic colorectal cancer undergoing treatment with aflibercept and FOLFIRI (fluorouracil, leucovorin, irinotecan). Most patients treated with this combination experienced either imp
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cb1f6c0354d72e7a6e2725f30d7ede7
https://pubmed.ncbi.nlm.nih.gov/31221542
Zobrazit plný text záznamu
9
Veterans affairs (VA) prostate cancer treatment (Tx) sequencing (VAPCaTS): A real-world study
Autor: Ambika Satija, Suna Park, Amanda De Hoedt, Ted P. Szatrowski, Catherine Nguyen, Rose Chang, Stephen J. Freedland, Thomas J. Polascik, Edward Drea, Mei Sheng Duh, Maral DerSarkissian, Aurore Aillaud
Publikováno v: Journal of Clinical Oncology. 38:54-54
54 Background: Limited real-world data are available on tx sequence for patients (pts) with metastatic hormone-sensitive PC (mHSPC) treated with androgen deprivation therapy (ADT) plus docetaxel (D) or abiraterone (A) who progress to metastatic castr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7d18b1a91b7ce05b4f3442c9e528706d
https://doi.org/10.1200/jco.2020.38.6_suppl.54
Zobrazit plný text záznamu
10
Clinical Practice Utilization and Outcomes with Rasburicase Vs Allopurinol for Patients at High Risk of Tumor Lysis Syndrome
Autor: Daniel Lyons, Scott Milligan, Edward Drea, Yvonne J Barnes, Janna Radtchenko
Publikováno v: Blood. 134:2203-2203
Introduction The efficacy of rasburicase vs allopurinol for the prevention of hyperuricemia (HU) of tumor lysis syndrome (TLS) has been demonstrated in clinical trials, yet studies evaluating these therapies in real-world clinical practice are lackin
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::144a21756b90590d0428b1b90564abe4
https://doi.org/10.1182/blood-2019-124319
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje